Mastrangelo, S.; Attinà , G.; Zagaria, L.; Romano, A.; Ruggiero, A.
Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine. Cancers 2022, 14, 5170.
https://doi.org/10.3390/cancers14205170
AMA Style
Mastrangelo S, Attinà G, Zagaria L, Romano A, Ruggiero A.
Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine. Cancers. 2022; 14(20):5170.
https://doi.org/10.3390/cancers14205170
Chicago/Turabian Style
Mastrangelo, Stefano, Giorgio Attinà , Luca Zagaria, Alberto Romano, and Antonio Ruggiero.
2022. "Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine" Cancers 14, no. 20: 5170.
https://doi.org/10.3390/cancers14205170
APA Style
Mastrangelo, S., Attinà , G., Zagaria, L., Romano, A., & Ruggiero, A.
(2022). Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine. Cancers, 14(20), 5170.
https://doi.org/10.3390/cancers14205170